Biomaterials for Diagnostic, Therapeutic, and Theranostic Applications

Dear Colleagues,

Theranostic formulations, integrating both diagnostic and therapeutic functions into a single platform, hold great potential for precision medicines. Recently, new advances in the bio-application of biomaterials are being reported for diagnostic, therapeutic, and theranostic applications. With the rapid development of emerging techniques of materials chemistry, biomaterials-based nanoplatforms have been strategically integrated with imaging contrast agents and therapeutic agents for various molecular imaging modalities including fluorescence imaging, magnetic resonance imaging, ultrasound imaging, or multimodal imaging, as well as for various therapeutic approaches including chemotherapy, gene therapy, hyperthermia therapy, photodynamic therapy, radiation therapy, or combination therapy, even imaging-guided therapy. The most encouraging aspect of these new developments is that some of the current research efforts start to implement the latest concepts of disease, that is, theranostics is evolving to incorporate aspects of both molecular imaging as well as personalized therapy.

The aim of this Special Issue is to develop more advanced biomaterials-based theranostics agents for anticancer, antibacterial, brain disease, and other relative biomedical applications. Both promising original scientific investigations and exhaustive reviews concerning this field are welcome. The scope is not restricted to biomaterials for theranostics; contributions on similar topics are also welcome.

The Special Issue contents are expected to include but not be limited to:

• Biomaterials for theranostics;
• Biomaterials for disease diagnosis;
• Biomaterials for treatments;
• Advanced biomaterials for healthcare applications.

Dr. Jianrong Wu
Prof. Dr. Yuanyi Zheng
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.